TY - JOUR
T1 - P.2.f.003 Deep transcranial magnetic stimulation (TMS) for treatment resistant depression
T2 - a 22-week maintenance study
AU - Rabany, L
AU - Harel, EV
AU - Bloch, Y
AU - Zangen, A
AU - Levkovitz, Y
PY - 2013
Y1 - 2013
N2 - Major depressive disorder (MDD) is a common disorder that presents a clinical challenge in terms of both acute and long term treatment. Residual symptoms are common and lead to high relapse rates in the short term and disability in the longer term.
AB - Major depressive disorder (MDD) is a common disorder that presents a clinical challenge in terms of both acute and long term treatment. Residual symptoms are common and lead to high relapse rates in the short term and disability in the longer term.
U2 - https://doi.org/10.1016/S0924-977X(13)70627-8
DO - https://doi.org/10.1016/S0924-977X(13)70627-8
M3 - Article
SN - 0924-977X
VL - 23
SP - S397
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
IS - Supplement 2
ER -